Bioptigen's Convertible Note Round

Bioptigen raised a round of funding on September 01, 2014. Investors include BlueTree Allied Angels.

Bioptigen, founded in 2004, is a medical device firm that develops and commercializes non-invasive scanning technology for ophthalmic procedures. The company describes the technology as being similar …

Articles about Bioptigen's Convertible Note Round: